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Nicotine serves as a feature-positive modulator of Pavlovian
appetitive conditioning in rats
M. I. Palmatier, J. L. Peterson, J. L. Wilkinson and R. A. Bevins
The present experiments examined whether a nicotine
state could set the occasion for a pairing between visual
cues and a rewarding outcome in rats. Following nicotine
administration, presentation of a conditional stimulus (CS;
light-on) was followed by brief access to a sucrose
solution. When saline was administered, the same CS was
presented but was not followed by any consequence. In
Experiment 1 , two groups assessed whether rats could
acquire this Pavlovian feature-positive discrimination via
different training procedures. An anticipatory food-seeking
conditioned response (CR) developed during the
CS on nicotine sessions but not on saline sessions
in both groups. In Experiment 2, centrally acting
antagonists of nicotinic acetylcholine and opiate
receptors (mecamylamine and naloxone, respectively)
dose-dependently blocked nicotine's control of the CR,
whereas the peripherally acting nicotinic antagonist
hexamethonium had no effect. Increasing or decreasing
the interval between nicotine administration and testing
also attenuated the CR. These results are consistent with

the hypothesis that nicotine can occasion appetitive
Pavlovian relations via its action at central nervous
system cholinergic receptors. Behavioural Pharmacology
15:183-194 O 2004 Lippincott Williams & Wilkins.

1ntroduc;tion

stimulus (CS) (e.g. saccharin solution) to water-deprived
rats. When the flavor is presented in a drug state (e,g.
morphine; Martin et nl., 1990), i t is followed by an
aversive outcome (i.e. lithium chloride injection). In the
absence of drug, access to t h e flavor is not followed by any
consequence. By the end of training, rats drink more
saccharin when morphine is absent than when morphine
is present.

Drug discrimination is a widely used animal model for the
self-reported or subjective effects of drugs in humans
(Schuster and Jolianson, 1988). One reason for the
widespread use of this model is that behavior controlled
by drug states is sensitive to pharmacological manipulations and reflects drug action at a cellular level
(Holtzman and Locke, 1988). Traditionally, operant
conditioning techniques are used to investigate the
stimulus effects of drugs. In such tasks, the presence
versus absence of an interoceptive drug stimulus guides
schedule-maintained behavior. For example, following
drug administration, a fixed number of responses on a
lever (e.g. left) may be reinforced by food. Following
saline administration, a distinctly different lever (e.g.
right) is reinforced on the same schedule. As a result of
this trainink the drug cue becomes a discriminative
stimulus (S ) that guides behavioral output. Thus, the
stimulus effects of the drug set the occasion upon which
left-lever pressing will be reinforced. Conversely, the
absence of the drug effects sets the occasion on which
right-lever pressing will be reinforced.
T h e investigation of drug discriminative stimuli has also
been extended to aversive Pavlovian conditioning situations. This preparation, termed discriminated taste
aversion, typically involves presenting a flavor conditional
0955-8810 @ 2004 Lippincott Williams & Wilkins
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T h e discriminated taste aversion procedure is a useful
tool for characterizing the behavioral and stimulus effects
of drugs. However, due to the aversive nature of the
associations (taste-illness), interpretation and extrapolation are necessarily contined to avoidance learning
situations. O n e question that has not been answered
sufficiently is whether the pharmacological effects of
drugs can guide Pavlovian conditioned approach behavior.
T o our knowledge, two studies (Parker et ad, 1994; Miller
et al., 2002) represent the only attempts to use a drug
state to control appetitive Pavlovian conditioning. In
these studies, the pharmacological effects of a drug (i.e.
methadone) resolved the ambiguity of two keylight
stimuli. For example, the presence of methadone signaled
that illumination of a green keylight was followed by
access to grain. T h e absence of methadone signaled that
grain followed illumination of a white keylight. Even
though responding was not required to receive grain
DOI: 10.1097/01 .fbp.0000132915.11693.8e
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access, pigeons pecked more at t h e keylight that was
followed by grain access in each drug state.
T h e fact that only two published studies (Parker et aL,
1994; Miller et dl., 2002) have examined the cueing
properties of drugs in Pavlovian approach situations is
surprising. Many modern theories of drug abuse implicate
Pavlovian conditioning processes in maintenance and
relapse of chronic drug use (e.g. Rose and Levin, 1991;
Robinson and Berridge, 1993; Siegel etal., 2000; Koob and
LeMoal, 2001). Notably, many of these models conceptualize drugs as outcomes (i.e. behavioral reinforcers or
unconditional stimuli) paired with purportedly neutral
environmental stimuli (but see Siegel et nl., 2000). These
'neutral' environmental stimuli acquire the ability to
evoke approach behavior as a result of this pairing.
However, contemporary researchers are beginning to
examine the interaction between appetitive stimuli and
drugs of abuse. For example, Caggiula and colleagues
(Donny et nl., 2003) have demonstrated that noncontingent nicotine infusions enhance lever pressing for
a reinforcing visual stimulus. Other laboratories have
demonstratcd that nicotine and amphetamine can
enhance che approach or secking behaviors controlled
by environmental cues (e.g. tonellight or clicker) that are
conditional signals for rewarding events (e.g. sucrose
pellets or water access, see w e l l and Berridge, 2000,
2001; Olausson et nl., 2003; 2004a, b). Finally, some
researchers have demonstrated that drug outcomes can
be associated with other drug cues that differ in intensity
and/or pharmacology (e.g. Revusky et dl., 1989; Kim et ad.,
1999).
Recent worlc from our laboratory reflects a similar
broadening of the role of Pavlovian conditioning processes
in drug abuse. For examplc, we recognize that not all
environmental cues are 'neutral'. In fact, some cues that
reliably occur with the pharmacological effects of drugs
will have positive motivational value. If the pharmacological effects of a drug were consistently paired with such
stimuli, then the drug might acquire the ability to evoke
approach or investigatory responses (see Alessi et aL,
2002). Indeed, we have demonstrated recently that
nicotine serves as a conditional stimulus for access to
sucrose (Besheer et al., 2004). Briefly, pairing nicotine
with a rewarding outcome (sucrose access) appeared to
give nicotine some conditioned excitatory value as
expressed by anticipatory food-seeking (i.e, goal tracking;
Farwell and Ayres, 1979).
T h e experiments reported here extend our previous work
by examining whether nicotine can control conditioned
approach evoked by an environmental cue (i.e. light CS).
In the nicotine state, this CS was immediately followed
by sucrose access; no programmed outcome occurred
when the CS was presented in a saline state. In this
situation, we conceptualized nicotine as a 'positive

feature' rather than a Pavlovian conditional stimulus
(e.g. Bouton and Swartzentruber, 1986; Holland, 1999;
Rescorla, 1986). That is, nicotine served as a cue that sets
the occasion on which the light CS will be followed by
sucrose. Throughout the remainder of this manuscript \ire
refer to the nicotine cue as a 'feature' of the discrimination or a 'modulator' of conditional responding, in order to
avoid terminologies that might infer behavioral mechanisms (i.e. conditioned facilitator; Rescorla, 1986; or
Pavlovian occasion setter; Holland, 1983).
Experiment 1 established that goal tracking developed
during the light CS, but only in the nicotine state. Followup tests explored some associative properties of nicotine
in this situation. For example, we examined whether
repeatedly presenting nicotine alone (i.e, extinction)
affected goal tracking when nicotine and the light CS
were subsequently tested together. In a similar preparation, we found that when nicotine was trained as a
conditional stimulus for sucrose (i.e. no light cues),
extinction of nicotine attenuated nicotine-evoked goal
tracking (Besheer et dl., 2004). Experiment 2 examined
some of the pharmacological properties of the putative
nicotine modulator. For example, both nicotinic acetylcholine and opiate receptor systems are involved in
cigarette smoking (e.g. Brauer et nl., 1999) and nicotine
withdrawal (e.g. Malin ef dl., 1993, 1998). Therefore, we
examined the effects of nicotinic acetylcholine receptor
(nAChR) and opiate receptor antagonist pre-treatments
on the ability of nicotine to occasion goal tracking to the
light CS. Thus, Experiment 1 explored the behavioral
conditions under which nicotine-specific goal tracking
could be established and expressed, while Experiment 2
began to examine the pl~armacological properties of
nicotine in the Pavlovian feature-positive paradigm.

Methods

1

Subjects

Eighteen experimentally na'ive male Sprague-Dawley rats
were obtained from Harlan (Indianapolis, Indiana, USA)
and housed individually in clear plastic tubs lined I
with wood-shavings in a temperature- and humiditycontrolled colony. Water was freely available; however, j
access to food was restricted, such that the rats were
maintained at 85% of their free-feeding weight
(mean = 320 IfI 7 g). This target 85% body weight was
increased by 2 g every 28 days to follow a typical growth 1
curve provided by the supplier. Experimental sessions
were conducted on consecutive days during t h e light
I
portion of a 12 h 1ight:dark cycle.
h

Apparatus

Seven standard operant chambers (Med Associates,
Georgia, Vermont, USA) were housed in a polyvinyl
chloride sound-attenuating cubicle, fitted with a fan t o
provide airflow and masking noise. Each chamber '
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Table 1

Design of Experiment 1

Group
Pre-training (n=6)
Discrimination (n=5)

Training 11 (40 sessions)

Training I (1 6 sessions)
Nic:L+
Nic:L+/Sal:L-

Extinction (6 sessions)

Nic:L+/Sal:LNic:L+ISal:L-

Nic:
Nic:

-

Tests
Nic:L-1Sal:LNic:L 1Sal:L -

-

Schematic of the procedures used in Experiment 1. Nic: or Sal: indicates that nicotine administration (0.4mglkg base, s.c.) or saline administration (0.90/0, s.c.),
respectively, preceded the session. L indicates a 30s presentation of light conditional stimulus (CS). or
indicates access to 26% sucrose or empty interval
immediately afler each CS, respectively. Iindicates separate sessions, which occurred on consecutive days in randomized order for each subject.

+ -

1

measured 30.5 x 24.1 x 21 cm (I x w x 11); the side walls
were aluminum and all stimulus elements were attached
to these walls. T h e ceiling and remaining walls of the
chamber were constructed of clear polycarbonate. One
side of each chamber was fitted with a liquid dipper in a
receptacle measuring 5.2 x 5.2 x 3.8 cm (1 x w x d). T h e
dipper arm had a 0.1 ml cup attached for sucrose delivery.
T h e receptacle was fitted with an infrared emitter/
detector unit, 1.2cm within the tray and 3cm from the
floor, to monitor head entries into the dipper. Two white
stilnulus lights (100 rnA, 2.54cm diameter) were
mounted on thc same wall, 14.6cm above the floor and
3.5 cm from the nearest perpendicular wall. Illumination
of these lights served as the CS. T h e apparatus was not
fitted with a house light; however, some ambient light
from the experimental room reached the closed cubicle
through the fan and ventilation outlets. A personal
computer with Med Associates interface and software
controlled the stimulus events and recorded dipper
entries throughout each session.
Drugs

(-)-Nicotine hydrogen tartrate, hexamethonium sulfate,
mecamylamine hydrochloride, and naloxone hydrochloride (Sigma/RBI, St. Louis, Missouri, USA) were dissolved
in saline and injected subcutaneously (SC) at a volume of
1 rnl/kg. Nicotine was brought to a pH of 7.0 0.2 with a
dilute NaOH solution. Nicotine doses are expressed as
the base form. Doses of all other compounds are
expressed as the salt form.
_+

Data analyses

T h e number of dipper entries was recorded in 30-second
(Experiment 1) or 15-second (Experiment 2) intervals.
Dipper entries (i.e. goal tracking) were also recorded
during the 4 s sucrose access periods. T h e main
dependent measure was the average elevation score for
each session. An elevation score for each trial was
calculated from dipper entries that occurred during the
light C S minus dipper entries that occurred during an
equivalent pre-CS period (Brooks and Bouton, 1994).
Thus, an average elevation score of 0 indicates equal goal
tracking during the CS and pre-CS periods across a
session; positive elevation scores indicate more goal
tracking during CS presentations. Average elevation
scores were analyzed with one-way or two-way analyses
of variance (ANOVAs) where appropriate. For pharmacological antagonist and temporal generalization tests
(Experiment 2), a significant one-way ANOVA was

followed-up by Dunnett's multiple comparisons test,
contrasting elevation scores from each condition with
scores from the control condition. When follow-ups
revealed significant differences, the test conditions were
compared to a 'no-nicotine' control condition (using
Bonferroni's error correction) that was derived from
elevation scores on the first trial of two saline training
sessions (see later). Statistical significance was set at
P I0.05 (two-tailed).
Procedures: Experiment 1

T h e protocol for each group is presented in Table 1.
Following dipper training (see later), rats were assigned
randomly to one of two groups [Pre-training (n = 6) or
Discrimination (n = 5 ) ] . Both groups received featurepositive discrimination training with nicotine (0.4mglkg)
as the feature. Different training procedures were
employed because this experiment was our first attempt
to establish nicotine-specific goal tracking to a discrete
CS. For example, we felt that the training procedures in
the Pre-training group (see later) might facilitate
acquisition of nicotine-specific goal tracking. T h e Discrimination group was included to assess the efficacy of a
more traditional drug discrimination training regime. T h e
nicotine training dose was chosen based on robust
operant performance in previous work (e.g. Chance et
ul.,1977; Pratt et al., 1983).
Dipper training

T h e first two 50-min sessions were dipper training; rats
were trained to access 26% sucrose (w/v) within 4 s ,
regardless of their location in the chamber. During the
first 25 min of the initial session, the cubicle door
remained open and the experimenter delivered sucrose,
For the last 25 min of this session, the cubicle door was
closed and the computer controlled sucrose deliveries
using a probability function. T h e probability of sucrose
delivery in a 4-s interval started at 0.167, approximately
2.5 sucrose deliveries/min, and gradually decreased to
0.133 (2 sucrose deliverieslper min) over the remainder
of the session. Dipper training continued on the following
day; however, the probability for sucrose delivery began at
0.133 and gradually decreased to 0.05 (approximately 0.75
sucrose deliverieslmin) .
Pre-training group

Modulatory training. Nicotine was injected s.c. 5 min
before each placement in the apparatus for the
first sixteen 20-min sessions following dipper training
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(Days 1-16). Each presentation of the light CS was
immediately followed by 4 s access to sucrose. On Days
17-56, half of the experimental sessions were preceded
by nicotine administration, the remaining sessions were
preceded by saline administration. T h e order in which
these two session types (Nicotine or Saline) occurred was
quasi-random across each 8-day cycle, with the constraint
that the same type of session did not occur on more than
two consecutive days. Each type of session was equally
represented within t h e cycles. T h e CS was followed by
4 s access to sucrose during nicotine sessions (Nic:L );
CS presentations were not followed by any programmed
consequence on saline sessions (Sa1:L-). A 4 s empty
interval occurred after CS offset in saline sessions, to
equate data sampling periods and total duration across
the session types.

+

On Days 1-12 there were eight CS presentations per
session; rats were shifted to four trials per session on Days
13-16 due to high dipper entrics during the first 12
sessions. T h e number of CS presentations per session was
then increased to six for the remainder of the training phase
(Days 17-56). Four Med-State Notation programs were
used to deliver the stimuli and record dipper entries. T h e
programs differed in regard to first trial onset (mean = 120 s,
range = 90-150 s) and the order of inter-trial intervals (ITIs,
CS offset to next CS onset). For each program, ITIs were
randomly chosen from a distribution (mean = 154s,
range = 94-214s); each interval occurred at least once per
session, with the same interval occurring no more than twice
in a session. Across an 8-day training cycle each program
controlled one nicotine session (sucrose delivered) and one
saline session (sucrose not delivered).
Extinction atd testing. Six consecutive feature extinction
sessions followed the acquisition phase (Days 57-62).
The nicotine feature may 'set the occasion' for responding to the light CS. On the other hand, some associative
models would predict that the nicotine feature enhances
responding to the light CS because of an excitatory
association between nicotine and sucrose (e.g. Rescorla
and Wagner, 1972). Accordingly, for both groups w e
attempted to extinguish any potential goal tracking (i.e.
conditioned excitation) that was evoked via a nicotinesucrose association. On each of the six extinction
sessions, nicotine was injected s.c. 5 min before placement in the experimentak chamber; the light CS and
sucrose were not presented (Nic: -) but dipper entries
were recorded. Two post-extinction test sessions (Days
63 and 64) followed feature extinction in counterbalanced order across subjects. These sessions lasted
20min and consisted of three presentations of the light
CS but not sucrose. One session occurred 5 min after
nicotine administration; the other test occurred 5 rnin
after saline administration. An equal number of rats
received nicotine and saline as the first solution tested.

Retention and testizg. Following the post-extinction test
(Day 64), rats were given free access to food for 30 days.
On Day 94 each rat was weighed and a new 85% target
weight was calculated. Food was then restricted such that
rats reached the new 85% target weight within the next 5
days (Days 95-99). Days 100 and 101 were retention
tests, 43 and 44 days from the end of acquisition training,
respectively. The procedures for these tests were similar
to the post-extinction tests except nicotine and saline
were tested in the opposite order for each rat.

i,

1'

s

Discrimination group

~Wodulatorytmining. For this group, discrimination training began on Day 1 (see Table 1). All 56 sessions were
parametrically identical to those described for the Pretraining group; however, these rats began training with
intermixed nicotine and saline sessions.
Extinction, retention, and testing. Feature extinction, postextinction, and retention test sessions were identical to
the Pre-training group. For the post-extinction test three
rats were tested with nicotine first; the remaining two
rats were tested with saline. During the 43-day retention
interval, rats were treated similarly to the Pre-training
group; testing order of the solutions was reversed for the
retention tests.
Procedures: Experiment 2

1
I

i

4

a

II
I
I

Dipper training

Dipper training included three 50-min sessions conducted on consecutive days. All three sessions were
entirely computer controlled; the probability function
decreased from 0.167 to 0.05 per 60s (approximately 2.5
to 0.75 sucrose deliverieslmin) over the three sessions.
Modulatory training

Training for these rats (n = 7) was similar t o the
Discrimination group of Experiment 1, except t h e CS
duration was reduced from the 30 s to 15 s and i t was
presented eight times in each 20-min training session.
Prior to testing there were 24 total training sessions in
three 8-day cycles (Days 1-24).

I
I

k

1

1

f
nAChR antagonist tests

Initial tests assessed the effects of pre-treatment with
hexamethonium (HEX, 2.5 or 5 mglkg s.c.), mecamylamine (MEC, 0.5 or 1.Omglkg s.c.), or saline (SAL) on
nicotine-modulated goal tracking. T h e highest dose of
mecamylamine is behaviorally effective without nonspecific effects on goal tracking in our laboratory (Besheer
et al., 2004). During the test phase, training cycles were
shifted to 7 days with six training sessions and one test in
each cycle. A performance criterion (see later) was
assessed on the last four training sessions of each
Saline, mecamylamine, and hexamethonium prement tests were intermixed in a randomized ord

"
Ei
$

r

Nicotine modulated Pavlovian appetitive conditioning Palmatier et a/. 187

each rat. After completing all test conditions, each rat was
randomly assigned a new randomized order. Thus, each
antagonist dose and saline was tested twice for each rat;
average elevation scores from these two tests were used
for analyses. T h e programs controlling test sessions were
identical to those for saline training sessions, except that
test sessions ended after 4min and included only one
presentation of the CS. SAL, MEC, or HEX was
administered 15 rnin before nicotine (0.4 mglkg) 20 rnin
before the start of the test session.
Naloxone tests

In subsequent tests, we assessed the effects of naloxone
(NAL; 0.0, 0.5, 2, 4 or 6mgIkg s.c.) pre-treatment on
nicotine-modulated goal tracking. Naloxone tests began
one cycle after rats completed mecamylamine and
hexamethonium testing. Naloxone was administered
5 min before nicotine ( i s . 10 rnin before the start of the
session). All other test parameters were identical to the
nAChR antagonist tests.
Temporal delay tests

Following t h e naloxone tests, each rat was tested with
various temporal delays (0, 5, 25, 50, 100, 125 or 200 min)
between nicotine administration and the start of the test
session. After s.c. injection of 0.4mglkg nicotine, rats
were returned to the home cage for the appropriate delay,
or were immediately placed in the apparatus (0-min
condition). T h e 5-min delay test was identical to the
deiay used in all other training and testing procedures and
was included as a baseline condition. Two of the longer
delays (50 and 100 min) were originally included to assess
t h e temporal persistence of the nicotine cue. However,
intervals of 125 and 200 min were added to the previously
randomized test blocks due to maintained conditioned
responding at 50 and 100 min.
Performance criterion

Each rat in Experiment 2 was required to complete a
minimum of three 8-day cycles before criterion was
assessed (i.e. Modulatory Training). To calculate the
criterion, mean elevation scores were contrasted across
nicotine and saline sessions for the last training cycle and
each test cycle. In order to meet the test criterion,
average elevation scores from nicotine sessions had to be
a value of 3 greater than average elevation scores from
saline sessions. A similar contrast was conducted on firsttrial data from the last nicotine and saline session of each
cycle. T h e criterion required a minimum difference score
of 1 for this first-trial contrast. T h e criterion elevation
scores were chosen n priori, based on scores from
Experiment 1. All rats met the criterion during the last
cycle of Modulatory Training, rats not meeting both
criteria during the test phase remained in the home cage
during t h e following test session.

Results
Experiment 1

T h e different procedures used for groups Pre-training and
Discrimination resulted in differential exposure to
nicotine (36 and 28 nicotine injections, respectively),
different amounts of sucrose access (264 and 192
deliveries, respectively), and different ratios of reinforced
to non-reinforced presentations of the CS ( 9 5 and 1:1,
respectively). Accordingly, data from each group were
analyzed separately.
Pre-training group

ModuIatoory training. Data from the acquisition phase are
presented in Fig. 1A. T h e initial one-way repeated
measures ANOVA revealed a main effect of Session
[F(15,75) = 8.3, P < 0.0011 on the first 16 (Nic:L )
sessions. A two-way repeated-measures ANOVA on
elevation scores from subsequent sessions revealed a
significant main effect of Drug [F(1,95) = 139.20,
P < 0.0011 and a significant Drug x Session interaction
[F(19,95) = 2.67, P < 0.011. The main effect of Session
was not significant [ F < 11. To assess potential statedependent effects of nicotine (see Discussion), we
compared first-trial elevation scores from the first
nicotine session (Nic:L+ ) and saline session (Sa1:L-)
of discrimination training. Responding to the light did not
differ on the first trial of these initial discrimination
sessions, t < 1 (see inset graph of Fig. 1A).

+

Extinction, retention and testing. Dipper entries were
recorded across each extinction session. The repeatedmeasures ANOVA revealed that the number of dipper
entries did not change across the extinction phase
[ F < 11. T h e average number of dipper entries for this
group was 50.5 ( k 11.0) on the first session and 57.3
( ? 12.7) on the last session. Elevation scores from t h e
post-extinction test are presented in the left pane1 of Fig.
1B. T h e repeated-measures ANOVA revealed significant
main effects of Drug [F(1,10) = 86.63, P < 0.003 J and
Trial [F(Z,10) = 8.55, P < 0.011. T h e Drug x Trial interaction was also significant [F(2,10) = 4.41, P < 0.051,
denoting a decrease in elevation scores across trials during
the nicotine session. Bonferroni's multiple comparisons
test confirmed this conclusion: elevation scores on the
nicotine session only differed significantly from the saline
session on Trial 1 [t=6.25, P < 0.0011. These withinsession extinction effects (left panel of Fig. 1B)
suggested that data from the first trial of the retention
tests would be the most informative. As such, only the
first trial of retention test sessions were included in
analyses (right panel of fig. 1B). Elevation scores were
similar across retention test sessions [t < 11.
Discrimination group

Modz~Intorytmining. Elevation scores from the acquisition phase are presented in Fig. 2A. The repeatedmeasures ANOVA revealed significant main effects of

I
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Fig. l

(A)

Acquisition

Sessions

(B)

Tests

Post-extinctiontest trials

Retention test

(A) Mean elevation scores (f1 SEM) across training sessions for the Pre-traininggroup of Experiment 1. Rats received a nicotine injection (0.4 mgl
kg base S.C.) 5 min prior to 16 training sessions (Days 1-1 6) in which a light conditional stimulus (CS) was followed immediately by 4 s access to
sucrose unconditional stimulus (US). Across the next 40 days, nicotine and saline sessions were intermixed; on saline sessions the light CS was
presented but was not followed by sucrose. Nicotine and saline sessions occurred on separate days, but are overlaid in order of occurrence to
facilitate comparison. The inset graph illustrates first trial elevation scores from the first saline session (session 17) and the 17th nicotine session
(session 17). (B) Mean elevation scores from each trial of the post-extinction tests (left), and the first trial of the retention tests (right). .k Indicates
that mean elevation score on nicotine session differs significantly from comparable saline session, P<0.05.

A

)

Nicotine modulated Pavlovian appetitive conditioning Palmatier et a/. 189

Drug [F(1,108) = 9.04, P < 0.051
and Session
[F(27,108) = 7.40, P < 0.011 and a significant Drug x
Session interaction [F(27,108) = 6.31, P < 0.011.
Extilction, refentiotl and testi~g. Dipper entries did not
change significantly across extinction sessions [ F < 11.
Average dipper entries were 52.4 ( + 16.1) on the first
session and 36.8 (+- 5.1) on the last scssion. Elevation
scores from the post-extinction test are presented in the
left panel of Fig. 2B. T h e repeated-measures ANOVA
revealed significant main effects of Drug [F(1,8) = 38.84,
P < 0.011 and of Trial [F(2,8) = 8.85, P < 0.011. T h e
Drug x Trial interaction was also significant [F(2,8) = 5.00,
P < 0.051, denoting within-session extinction on the
nicotine test. Bonferroni's multiple comparisons test
revealed that elevation scores on the nicotine session
only differed significantly from the saline session on Trial 1
[f = 5.92, P < 0.0011. Elevation scores from the retention
test (right panel of Fig. 2B) were significantly higher on
the nicotine session than the saline session for this group
[t(4) = 2.91, P < 0.051.
Experiment 2
Modulatory training

Data from the acquisition phase are presented in Fig. 3A.
T h e repeated-measures ANOVA revealed significant
main effects of Drug [F(1,66) = 72.29, P < 0.0011 and
Session [F(11,66) = 6.73, P < 0.0011, as well as a
significant Drug x Session interaction [F(l l,66) = 8.96,
P < 0.001].
nAChR antagonist tests

Elevation scores from the nAChR antagonist tests are
presented in Fig. 3B. T h e one-way repeated-measures
ANOVA was significant [F(4,34) = 7.19, P < 0.0011;
follow-up comparisons revealed lower elevation scores in
the mecamylamine pre-treatment conditions (0.5 and
I mg/kg), relative to saline pre-treatment [Ps < 0.051.
Hexamethonium did not affect elevation scores
[Ps > 0.051. Elevation scores from the mecamylamine
pre-treatment tests were compared to a 'no-nicotine'
baseline for further characterization. This no-nicotine
baseline was derived from the first-trial elevation scores
of saline training sessions that immediately preceded
1 mglkg mecamylamine tests. Pre-treatment with 0.5 mg/
Irg mecamylamine yielded significantly higher elevation
scores than the no-nicotine control [ P < 0.0011, Elevation
scores after 1mg/kg mecamylamine pre-treatment were
statistically similar to this control [P > 0.051.
Naloxone tests

Elevation scores from the naloxone tests are presented in
Fig. 3C. T h e one-way repeated-measures ANOVA was
significant [F(4,34) = 12.04, P < 0.0011, with all doses of
naloxone significantly decreasing elevation scores
[Ps < 0.051. Another no-nicotine control condition was

derived from the first-trial elevation scores of saline
training sessions that immediately preceded the 6 mg/kg
naloxone tests. Elevation scores from the 0.5 mg/kg
naloxone pre-treatment test were higher than the nonicotine condition [ P < 0.051. T h e remaining naloxonc
pre-treatment doses (2, 4 and 6 mg/kg) yielded similar
elevation scores to the no-nicotine control condition
[Ps > 0.051.
Temporal delay tests

Data from the temporal effect tests are presented in
Fig. 3D. T h e one-way repeated-measures ANOVA was
significant [F(6,48) = 22.06, P < 0.0011; follow-up tests
revealed that elevation scores from the 25- and 50-min
tests were similar to those of the 5-min condition
[Ps > 0.051. In all other test conditions, elevation scores
differed significantly from the 5-min condition
[Ps < 0.011. Elevation scores from the 100- and 125-min
tests differed significantly from a no-nicotine control
condition [Ps 5 0.0011, derived from first-trial elevation
scores of the saline training sessions that preceded 5-mi11
delay tests. The 0-min and 200-min test conditions did
not differ from this control [Ps 2 0.051.

Discussion
T h e pharmacological effccts of nicotine signaled when a
light CS would be followed by sucrose, Accordingly, rats
engaged in more food-seeking behaviors (i.e, goal
tracking) during the light when nicotine was present
than when nicotine was absent. This 'modulatory' control by nicotine developed whether training began with
16 consecutive Nic:L+ sessions or with intermixed
Nic:L
and Sal:L- sessions (Experiment 1). Notably,
nicotine-specific goal tracking in the Discrimination
group seemed to be more variable relative to the Pretraining group. At first glance, this difference might be
attributed to the different training parameters. However,
in Experiment 2 the training procedures were similar to
the Discrimination group but resulted in much less
variability. Perhaps more variability in the Discrimination
group was due to a longer CS duratiol~ (30s in
Experiment 1 versus 15 s in Experimellt 2) or to the
smaller sample size in this group (12 = 5); nevertheless,
further research will be required to determine the source
of this variability. Experiment 2 extended the nicotinespecific goal tracking finding to a shorter CS duration (i.e.
15 s) and began to elucidate neuropharmacological
mechanisms. To our knowledge, these experiments are
the first to investigate the behavioral and neuropharmacological properties of a positive nicotine feature in an
appetitive Pavlovian conditioning preparation in rats.
Such a preparation could be an important tool for
examining the associative and stimulus propertiev of
drugs, given our demonstration of rapid acquisition and
stable rates of behavior over a prolonged period of time
(e.g. Experiment 2).
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Fig. 2

(A)

Acquisition

Sessions

(6)

Tests

Post-extinctiontest trials

Retention test

(A) Mean elevation scores ( *1 SEM) across training sessions for the Discriminationgroup of Experiment 1. For this group, training wa
that of the Pre-training group (see Fig. 11, except that all nicotine and saline sessions were intermixed. Nicotine and saline sessions
separate days, but are overlaid in order of occurrence to facilitate comparison. (B) Mean elevation scores for each trial of the post-ext
(left), and the first trial of each retention test (right). 7t Indicates that mean elevation score on nicotine session differs significantly
session, P<0.05.
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Fig.3

(A)
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(C)
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(A) Mean elevation scores (f1 SEM) across training sessions for rats in Experiment 2. For these rats, training was similar to the Discrimination
group from Experiment 1 (see Fig. 2 ) ; all rats met the performance criterion by Session 24 and testing began on Session 26. Mean elevation scores
on (B)nicotinic acetylcholine receptor (nAChR) antagonist pre-treatment tests, (C)naloxone pre-treatment tests, and (D) temporal delay tests are
shown. # Indicates drug pre-treatment or delay condition was significantly different from saline pre-treatment or 5-min delay controls, respectively,
P<0.05; +, indicates drug pre-treatment or delay test condition differs significantly from no-nicotine control condition, P<0.05.
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In order to fully appreciate the associative and stimulus
properties of nicotine in this preparation, we must
examine the means by which nicotine controls goal
tracking. Possibly, the pharmacological effects of nicotine
provide a stimulus context that modulates a light-sucrose
relation (e.g. Bouton and Swartzentruber, 1986). Alternatively, a state-dependent learning account suggests that
the association between the light and sucrose is not
readily recalled and/or performed outside of the nicotine
drug-state (e.g. Cunningham, 1979). Our enthusiasm for
this state-dependence account is diminished by some of
the results from the Pre-training group in Experiment 1.
During the initial nicotine training sessions (Nic:L -I-),
elevation scores for this group increased steadily,
suggesting that an association developed between the
light CS and the sucrose unconditional stimulus (US).
Because of the training protocol, rats in the Pre-training
group may have acquired a nicotine-dependent associa-

tion. If so, goal tracking to the light CS should b e
disrupted by removal of the nicotine state. However, goal
tracking in the no-drug state did not differ from goal
tracking in the nicotine state (see inset graph of Eg. lA),
suggesting that the light-sucrose association was not
dependent on the nicotine state.
Another alternative to the modulatory account is based on
the perfect correlation between sucrose delivery and the
nicotine state. Arguably, higher elevation scores on
nicotine sessions could be the result of conditioned
excitation evoked by nicotine (e.g. Besheer et a l , 2004)
summating with weak excitation evoked by the light CS
( i s . 50% pairing with sucrose delivery). To test this
account, we repeatedly presented the putative conditioned excitor (nicotine) in the absence of the sucrose
US. Arguably, this treatment should have reduced t h e
ability of nicotine to evoke a conditional response (i.e.
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extinction; Pavlov, 1927). However, nicotine still controlled goal tracking during the light CS, despite 120 min
of extinction treatment. These data provide preliminary
evidence that goal tracking to the light CS was
independent of a direct association between nicotine
and sucrose. However, we must stress the use of the word
'preliminary'. For example, relative ro the training phase
(56 sessions) the extinction phase (six sessions) was
short. Regardless, this preliminary result is encouraging
and we are currently conducting a more complete analysis
of nicotine feature extinction.
One reason for the brevity of the extinction phase was our
concern about the sensitivity of this task to the passage of
time. Since this was the first study of its type in rodents,
we had no way of knowing how the passage of time might
affect performance. Extensive feature extinction might
disrupt modulatory co~ltrolby attenuating the conditional
stimulus properties of nicotine (Pavlov, 1927; Besheer et
nl., 2004). Alternatively, a long interval between training
and testing could affect performance due to decay of
associative networks involving nicotine, light CS, and
sucrose over time (e.g. forgetting; Bouton, 1994). From
this perspective, an important additional test of this
preparation was to examine performance after a long
retention interval (i.e. G weeks). O n t h e retention test,
the Discrimination group exhibited more goal tracking t o
the light during the nicotine session, indicating that t h e
extinction treatment, post-extinction test, and long
retention interval did not disrupt the ability of nicotine
to occasion the goal tracking CR.
For the Pre-training group, the retention test did not
reveal differential goal tracking across nicotine and saline
drug states. This failure resulted from high levels of goal
tracking during the light on both nicotine and saline test
sessions (see right panel of Fig. 1B). This type of
retention failure would occur if the first association
(L ) was better retained than tlie subsequcnt association (L-; e.g. Bouton et czd, 1999). Recall that the light
CS was initially paired with sucrose on every trial for t h e
Pre-training group, but not for the Discrimination group.
Moreover, for the Pre-training group, the light CSsucrose US association was independent of the nicotine
state. Accordingly, a retention test might be most
sensitive to initial learning, which would b e expressed
as nicotine-independent goal tracking for the Pre-training
group. Although this account fits the data rather well,
alternatives sucli as differential sensitivity to the feature
extinction and/or post-extinction tests cannot be eliminated at present.

+

Many of the behavioral effects of nicotine rely on its
action a t central nervous system nAChRs. For example,
nAChR antagonists that pass the blood-brain barrier (e.g.
mecamylamine) attenuate the reinforcing (Corrigall and

Coen, 1989), discriminative sti~nulus (Stolerman et a/.,
1984), and avoidance learning (Kumar etnl., 1983) effects
of nicotine. However, nAChR antagonists that do not pass
the blood-brain barrier (e.g. hexametl~onium) do nor
impact these effects of nicotine (Kumar et nl., 1983;
Stolerman et nl., 1984; Corrigall and Coen, 1989). In
Experiment 2, the ability of nicotine to serve as a
modulatory cue was dose-dependently attenuated by
mecamylamine pre-treatment, but not by hexamethonium. This pattern is consistent with previous reports
that the discriminative stimulus effects (e.g. Stolerman d
dl., 1984) as well as the conditional stimulus properties
(Besheer etnl., 2004) of nicotine are mediated by central
nAChRs.
Naloxone also attenuated goal tracking occasioned by
nicotine in a dose-dependent manner. One reason for this
attenuation could be that antagonism of opioid receptors
decrements some of the 'downstream' effects of nicotine,
For example, stimulation of nicotinic receptors results in
the release of endogenous opioids (e.g. Hexum and
Russet, 1987); presumably naloxone administration would
antagonize the effects of this opioid release. Also,
nicotine-induced dopamine release in the nucleus
accumbens is attenuated by pre-treatment with naloxone
(Tanda and DiChiara, 1998). Blocking these opiaterelated downstream effects of nicotine could attenuate
some aspect (e.g, salience) of the nicotine stimulus.
Notably, the doses of naloxone that antagonized nicotinespecific goal tracking were mucli higher than those used
to block the effects of morphine and other prototypical
mu opioid agonists (e.g. 0.1 mgllrg; Stolerman etnl., 2002).
Perhaps attenuation of nicotine-specific goal tracking was
due to antagonism at both mu and delta opiate receptors
(e.g. Takemori and Portoghese, 1984; Tiseo and Yaksh,
1993). Activation of kappa opioid receptors via selective
agonists attenuates the effects of nicotine in the central
nervous system (e,g. Oka et nl., 1998; Maisonneuve and
Glick, 1999; Hahn et nl., 2000). Therefore, decrement of
nicotine-specific goal tracking was probably not the result
of naloxone antagonism at kappa receptors. On the other
hand, naloxone, which produces a perceptible interoceptive stimulus on its own (e.g. Smurthwaite et ul., 1992),
may have attenuated goal tracking via generalization
decrement (Pavlov, 1927). Pre-treatments with naloxone
(especially at higher doses) could make interoceptive
nicotine cues dissimilar from the originally trained
modulator. This difference between interoceptive cues
would result in a loss of goal tracking controlled by
nicotine. Distinguishing between these alternatives will
require further investigation.
In Experiment 2, changing the time between nicotine
injection and the start of the experimental sessions
altered the ability of nicotine to control goal tracking to
tlie light CS. T h e effects of varying the interval between
nicotine injections and test sessions are consistent with
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evidence from previous studies on the behavioral and
physiological time course of nicotine (Pratt et nl., 1983;
Ghosheh ef Q/., 1999). For example, a loss of goal tracking
on the 0-min test indicates that nicotinc had not
accumulated to sufficient plasma and brain concentrations to produce the stimulus that occasioned goal
tracking (see Pratt p t rzL, 1983). T h e attenuation of goal
tracking from 100 to ZOO min likely reflects significant
decreases in the plasma and brain concentrations of
nicotine over similar intervals (Ghosheh et nL, 1999;
Pratt et al., 1983). For example, in an operant nicotinc
(0.4mglkg base, LC.) discrimination using male hooded
rats, nicotine-appropriate responding peaked from 2.5
to 10 min post-injection and reached saline levels by
160min (Pratt et al., 1983). In the same study, plasma
nicotine concentration peaked between 2.5 and 10
min post-injection and declined considerably by
160 min. Using male Sprague-Dawley rats, Ghosheh et nlI
(1999) determined that brain concentrations of nicotine
(0.8 mglkg base, s.c.) peaked at approximately 5 min postinjection and declined significantly between 60 and
240min; the brain half-life of nicotine was determined
to be approximately 52 min.
These data represent an important extension of previous
investigations of drug-modulated Pavlovian conditioning
(e.g. Miller e t nl., 2002; Skinner et n/I, 1998). Establishing
that an appetitive Pavlovian CR can be modulated by
nicotine in rodents will facilitate future investigation of
the associative and stimulus properties of nicotine. Given
that our findings are generally comparable with operant
nicotine discriminations (e.g. Pratt et al., 1983; Stolerman
et al., 1984), this model might also be well suited for
examining the neurobiological substrates of the subjective effects of nicotine. Current research in our laboratory
is extending these modulatory properties of nicotine to
other drug states, including amphetamine (1.0 mglkg)
and clllordiazepoxide (5.0 mgllrg), suggesting chat this
preparation may be an efficient and informative way to
investigate the subjective effects of drugs in general. At
minimum, examining the ability of a drug state to control
conditioned approach will complement our understanding of its ability to control conditioned avoidance (e.g.
Martin et nl., 1990) and sclredule-controlled behavior (e.g.
Pratt et nl., 1983).

,

Further investigations that reveal the associative mechanisms by which drug modulators operate will inform
theories of drug abuse, and might also contribute to our
understanding of basic Pavlovian conditioning processes.
One notable extension of the current studies will be to
examine whether nicotine can serve as a 'negative
feature'. That is, if sucrose followed the discrete CS in
the saline state but not in the nicotine state, would the
nicotine cue set the occasion for withholding the goal
tracking CR? Such experiments are currently under way
in our laboratory, and the answer appears to be

193

affirmative. One question that we have not answered is
whcther such a training protocol could establish the
nicotine cue as a conditioned inhibitor (e.g. Pavlov, 1927).
Indeed, the ~licotine feature has both a serial and
simultaneous relationship with the light CS. Holland
and Lamarre (1984) found that negative features
presented in simultaneous compound with a CS serve
as conditioned inhibitors, whereas negative features
presented in serial compound with the CS occasion less
conditional responding through some other mechanism.
Therefore, the associative and pharmacological mechanisms by which a contextual cue such as nicotine occasions
the absence of goal tracking might be considerably
different from the manner in which nicotine occasions
conditioned approach. Accordingly, research comparing
the behavioral and pharmacological processes underlying
the ability of nicotine to serve as a positive versus
ncgative feature is needed. Other studies might exanline
whether drug stimuli can occasion relationslrips between
environmental cues and drug outcomes. More specifically,
could the interoceptive effects of alcohol occasion a
relationship between the smell of smoke and nicotine
delivery? Do drug contexts function similarly to other
Pavlovian occasion setters (e.g. Holland, 1999)? That is,
would a drug state that occasions conditioned approach
with one CS transfer that control to another similarly
trained CS (cf. Parker etnl., 1994)? Do drug stimuli servc
as Pavlovian occasion setters in humans, and are these
drug contexts involved in maintaining drug use, relapse,
and/or polydrug abuse? These questions about drug
stimulus 'contexts' and their role ill Pavlovian or
stimulus-outcome associations delineate an important
and exciting avenue for future research.
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